But numbers without records are numbers you will eventually forget, misremember, or confuse
~ AlphaMD At AlphaMD, we frequently encounter questions and concerns regarding testosterone therapy and its effects on mood and behavior
Mechanism difference Semaglutide (GLP-1 agonist): appetite regulation, satiety, improved glycemic control (New England Journal of Medicine) Tirzepatide (GLP-1/GIP agonist): broader incretin effects, robust appetite/weight effects (New England Journal of Medicine) AOD-9604: targeted fat-metabolism signaling
Peptide therapy amplifies this process by introducing peptides that stimulate these healing pathways more effectively
CagriSema showed 22.7% at 68 weeks, but Novo Nordisk is running a direct head-to-head trial (NCT06131437) that will settle the comparison in a way indirect data cannot
Recovery still feels slow Sleep isnt as deep as it used to be Fat is hanging on